Annual Cash & Cash Equivalents
$26.21 M
-$20.30 M-43.65%
December 31, 2023
Summary
- As of February 25, 2025, PROF annual cash & cash equivalents is $26.21 million, with the most recent change of -$20.30 million (-43.65%) on December 31, 2023.
- During the last 3 years, PROF annual cash & cash equivalents has fallen by -$57.70 million (-68.76%).
- PROF annual cash & cash equivalents is now -68.76% below its all-time high of $83.91 million, reached on December 31, 2020.
Performance
PROF Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$27.12 M
-$6.96 M-20.41%
September 1, 2024
Summary
- As of February 25, 2025, PROF quarterly cash and cash equivalents is $27.12 million, with the most recent change of -$6.96 million (-20.41%) on September 1, 2024.
- Over the past year, PROF quarterly cash and cash equivalents has dropped by -$14.06 million (-34.14%).
- PROF quarterly cash and cash equivalents is now -67.68% below its all-time high of $83.91 million, reached on December 31, 2020.
Performance
PROF Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
PROF Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -43.6% | -34.1% |
| 3 y3 years | -68.8% | -34.1% |
| 5 y5 years | +16.3% | -34.1% |
PROF Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -61.0% | at low | -59.6% | +3.5% |
| 5 y | 5-year | -68.8% | +77.1% | -67.7% | +83.3% |
| alltime | all time | -68.8% | +1682.1% | -67.7% | +1974.4% |
Profound Medical Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $27.12 M(-20.4%) |
| Jun 2024 | - | $34.08 M(-17.2%) |
| Mar 2024 | - | $41.18 M(+57.1%) |
| Dec 2023 | $26.21 M(-43.6%) | $26.21 M(-22.0%) |
| Sep 2023 | - | $33.63 M(-14.4%) |
| Jun 2023 | - | $39.27 M(-8.6%) |
| Mar 2023 | - | $42.98 M(-7.6%) |
| Dec 2022 | $46.52 M(-30.7%) | $46.52 M(+0.7%) |
| Sep 2022 | - | $46.21 M(-13.2%) |
| Jun 2022 | - | $53.23 M(-11.5%) |
| Mar 2022 | - | $60.12 M(-10.5%) |
| Dec 2021 | $67.15 M(-20.0%) | $67.15 M(-7.0%) |
| Sep 2021 | - | $72.22 M(-2.1%) |
| Jun 2021 | - | $73.77 M(-6.0%) |
| Mar 2021 | - | $78.51 M(-6.4%) |
| Dec 2020 | $83.91 M(+467.0%) | $83.91 M(+1.7%) |
| Sep 2020 | - | $82.48 M(+101.3%) |
| Jun 2020 | - | $40.98 M(-6.1%) |
| Mar 2020 | - | $43.65 M(+194.9%) |
| Dec 2019 | $14.80 M | $14.80 M(-28.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $20.57 M(+31.8%) |
| Jun 2019 | - | $15.61 M(-22.9%) |
| Mar 2019 | - | $20.26 M(-10.1%) |
| Dec 2018 | $22.53 M(+155.2%) | $22.53 M(-17.3%) |
| Sep 2018 | - | $27.25 M(+12.0%) |
| Jun 2018 | - | $24.33 M(-17.4%) |
| Mar 2018 | - | $29.44 M(+233.4%) |
| Dec 2017 | $8.83 M(-43.0%) | $8.83 M(-32.8%) |
| Sep 2017 | - | $13.15 M(+60.3%) |
| Jun 2017 | - | $8.20 M(-35.3%) |
| Mar 2017 | - | $12.67 M(-18.3%) |
| Dec 2016 | $15.50 M(+104.4%) | $15.50 M(+113.0%) |
| Sep 2016 | - | $7.28 M(+216.8%) |
| Jun 2016 | - | $2.30 M(-57.3%) |
| Mar 2016 | - | $5.38 M(-29.0%) |
| Dec 2015 | $7.58 M(+415.5%) | $7.58 M(-23.3%) |
| Sep 2015 | - | $9.89 M(-52.7%) |
| Jun 2015 | - | $20.91 M(+1499.4%) |
| Mar 2015 | - | $1.31 M(-19.6%) |
| Dec 2014 | $1.47 M | - |
| Sep 2014 | - | $1.63 M |
FAQ
- What is Profound Medical annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Profound Medical?
- What is Profound Medical annual cash & cash equivalents year-on-year change?
- What is Profound Medical quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Profound Medical?
- What is Profound Medical quarterly cash and cash equivalents year-on-year change?
What is Profound Medical annual cash & cash equivalents?
The current annual cash & cash equivalents of PROF is $26.21 M
What is the all time high annual cash & cash equivalents for Profound Medical?
Profound Medical all-time high annual cash & cash equivalents is $83.91 M
What is Profound Medical annual cash & cash equivalents year-on-year change?
Over the past year, PROF annual cash & cash equivalents has changed by -$20.30 M (-43.65%)
What is Profound Medical quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of PROF is $27.12 M
What is the all time high quarterly cash and cash equivalents for Profound Medical?
Profound Medical all-time high quarterly cash and cash equivalents is $83.91 M
What is Profound Medical quarterly cash and cash equivalents year-on-year change?
Over the past year, PROF quarterly cash and cash equivalents has changed by -$14.06 M (-34.14%)